Monitoring of endothelial activation markers during physiological pregnancy

Česká verzia

Authors: J. Procházková ¹; I. Dhaifallah ²; A. Měchurová ³; R. Pilka ²; O. Šimetka ⁴; L. Slavík ¹; J. Úlehlová ¹; M. Lubušký ²; M. Procházka ²
Authors place of work: Hemato-onkologická klinika FN a LF UP, Olomouc, přednosta prof. MUDr. K. Indrák, DrSc. ¹; Porodnicko-gynekologická klinika FN a LF UP, Olomouc, přednosta doc. MUDr. R. Pilka, Ph. D. ²; Ústav pro péči o matku a dítě, Praha, ředitel doc. MUDr. J. Feyereisl, CSc. ³; Porodnicko-gynekologická klinika FN, Ostrava, přednosta MUDr. O. Šimetka ⁴
Published in the journal: Ceska Gynekol 2010; 75(2): 92-100

Summary

Aim of the study:
To establish endothelial activation markers which could uncover endothelial damage during physiological pregnancy.

Type of study:
Prospective study.

Method:
We examined 403 pregnant women with a physiological pregnancy. Venous blood samples were collected from the women at the beginning of the pregnancy, a second sample was collected in the interval 24-28 weeks gestation. Parameters were examined using methods: t-PA – ELISA, PAI-1 – ELISA, vWF Ag – EIA ePCR – ELISA, MMP-2,9 – ELISA with fluorogenic detection, TIMP-2 – ELISA, endothelial microparticles - flow cytometry.

Results:
The level of vWF antigen increased during the entire course of pregnancy (in the I. trimester the average level was 152,32%, in the II. and III. trimester 173.34% and 216.20% respectively). At the same time, vWf activity also increased (I. trimester average level 130.20%, II. and III. trimester 150.09% and 181.91% respectively). The level of thrombomodulin significantly increased during pregnancy (I. trimester average level 19,05 ng/ml, II. and III. trimester 28,47 ng/ml and 39,86 ng/ml respectively). The level of soluble form of EPCR increased during pregnancy (I. trimester average level 201.76 ng/ml, II. and III. trimester 274.68 ng/ml and 324.07 ng/ml respectively). The level of PAI–1 increased during the entire course of pregnancy (I. trimester average level 36.14 ng/ml, II. and III. trimester 50.07 ng/ml and 60.12 ng/ml respectively). The level of t- PA did not change significantly during the course of pregnancy (I. trimester average level 2.48 ng/ml, II. and III. trimester 2.97 and 3,34 ng/ml respectively). The levels of MMP-2 (I. trimester average level 9043,76 RFU, II. and III. trimester 9315.38 and 8800.27 RFU respectively), MMP-9 (I. trimester average level 8371.90, II. and III. trimester 8290.81 and 7470.50 respectively), TIMP-2 (I. trimester average level 92.5 ng/ml, II. and III. trimester 98.5 and 96.5 ng/ml respectively) or endothelial microparticles (I. trimester average level 3838.38 particles/μl, II. and III. trimester 3836.59 and 3650.59 particles/μl respectively) did not change significantly throughout the individual trimesters.

Conclusion:
We confirmed the hypothesis regarding the significant influence pregnancy has on changes in levels of these markers.

Key words:
endothelium, pregnancy, activation, preeclampsia.

Zdroje

1. Blann, AD. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol Haemostasis Thrombosis 2005, 34.

2. De Caterina, R., Libby, P. Endothelial dysfunctions and vascular disease. Viley and sons: Blackwell Publishing, 2007, p. 3-25.

3. Hoffbrand, AV., Catovsky, D., Tuddenham, EGD. Postgraduate Hematology. Viley and sons: Blackwell Publishing, 2005, p. 787-792.

4. Kvasnička, J. Trombofilie a trombotické stavy v klinické praxi. Praha: Grada Publishing, 2003, s. 40-65.

5. Pecka, M. Laboratorní hematologie v přehledu. Fyziologie a patofyziologie hemostázy. 2004, s. 22-24, 87-97, 113-118.

6. Pilka, R., Hrachovec, P. Matrix metaloproteinázy a menstruace. Čes Gynek 2003, 68, s. 36-40.

7. Šimetka, O., Brychtová, P., Procházková, J., Procházka, M. Laboratorní změny aktivace endotelu u syndromu HELLP. Gynekolog 2008, 2, s. 48-53.

8. Holmes, VA., Wallace, JMW. Haemostasis in normal pregnancy: a balancing act? Biochemical Society Transactions 2005, 33, part 2, p. 428-432.

9. Brenner, B. Haemostatic changes in pregnancy. Thromb Res 2004, 114, p. 409-414.

10. Buffa, MC., Valsecchi, L., Fausto, A. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Tromb Haemost 1998, 79, p. 1092-1095.

11. Stirling, Y., Woolf, L., North, WR., et al. Haemostasis in normal pregnancy. Thromb Haemost 1984, 52, p. 176-182.

12. Ishii, A., Yamada, R., Hamada, H. t-PA activity in peripheral blond obtained from pregnant women. J Perinat Med 1994, 22, p. 113-117.

13. Bremme, K., Ostlund, E., Almquist, I. Enhanced thrombin generation and fibrinolytic activity in the normal pregnancy and the puerperium. Obstet Gynecol 1992, 80, p. 132-137.

14. Bretelle, F., Sabatier, F., Desprez, D., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy complicated by preeclamsia or intrauterine growth restriction. Thromb Haemost 2003, 89, p. 486-492.

15. VanWijk, MJ., Svedas, E., Boer, K., et al. Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 2002, 187, p. 1686-1693.

16. Raffaetto, JD., Khalil, RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75(2), p.346-59. Epub 2007 Jul 7. Review.